SEMBL T28749
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SEMBL, a novel inhibitor of DNA binding of NF-kappaB component p65 in vitro, inhibits NF-kappaB and cellular invasion in ovarian carcinoma ES-2 cells.
CAS nr:
1443448-82-5
Purity:
98%
Molecular Weight:
233,22
SMILES:
C=C([C@H](NC(C1=CC=CC=C1O)=O)CO2)C2=O
Formula:
C12H11NO4
Pathway:
Target:
